City Therapeutics, Inc. (CTY)

US · Healthcare · Biotechnology

$18.25+6.91%

Last close · 2026-11-06

Latest quarter · ended 2020-06-30

Revenue

$524.0M

Revenue YoY

-74.5%

Net profit

$430.0M

Profit YoY

-9.9%

Net margin

82.1%

Market cap

$1.05B

Forward P/E

0.0

P/B

0.00

Book value

$-24.91

EPS (TTM)

$-2.53

52-week high

$23.88

52-week low

$18.77

50-day MA

$21.16

200-day MA

$21.16

Insiders

7.37%

Institutions

37.64%

Document	Date
Charter / bylaws change · Q4 2026 HEADLINE NUMBERS • City Therapeutics, Inc. filed a Form 8-K dated October 15, 2026, with the report signed October 19, 2026. • The company’s common	2026-10-19

Readable in the app.

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for City Therapeutics, Inc. — free to start.

Data updated 2026-11-07.